13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001858703
申报总市值
US$6.6亿
US$6.6亿
73 檔
22.5%
在 Q1 2025 的 13F 官方备案中，Blue Owl Capital Holdings LP 管理的美股投资组合规模来到 US$6.6亿，整体持股档数为 73 档。
在 Q1 2025，Blue Owl Capital Holdings LP 操作展现出积极扩展与加仓意向。本季共新建仓 7 个新仓位，并对 16 个既有持股进行加仓（合计增持 23 档），相较减仓与清仓仓位显著占优。
在资产配置集中度方面，Blue Owl Capital Holdings LP 的前 5 大核心持股（包含 NCDL, OBDC, CGEM 等）合计占整体申报市值的 22.5%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NCDL | Nuveen Churchill Direct Lend | 股票-其他 | 22.12% | -3.32% | — | |
| 2 | OBDC | Blue Owl Capital CORP | 股票-金融 | 9.67% | -2.73% | — | |
| 3 | CGEM | Cullinan Therapeutics Inc | 股票-其他 | 5.95% | -3.07% | +2.74% | |
| 4 | EVCM | Evercommerce Inc | 股票-其他 | 5.34% | — | — | |
| 5 | TRML | Tourmaline Bio Inc | 股票-其他 | 5.09% | — | -3.91% | |
| 6 | CNDT | Conduent Inc | 股票-其他 | 4.96% | -0.62% | +1.28% | |
| 7 | ✓ | Engene Holdings Inc | 股票-其他 | 4.74% | -8.08% | EXIT | |
| 8 | HLLY | Holley Inc | 股票-其他 | 4.41% | -1.81% | +77.84% | |
| 9 | LRMR | Larimar Therapeutics Inc | 股票-其他 | 3.31% | -4.40% | +2.69% | |
| 10 | TQQQ | Proshares Ultrapro Qqq | ETF-其他 | 3.23% | — | — | |
| 11 | CVEO | Civeo CORP | 股票-其他 | 2.58% | -1.28% | EXIT | |
| 12 | IRON | Disc Medicine Inc | 股票-其他 | 2.25% | — | +16.63% | |
| 13 | ELDN | Eledon Pharmaceuticals Inc | 股票-其他 | 1.99% | -0.84% | -7.14% | |
| 14 | CMPX | Compass Therapeutics Inc | 股票-其他 | 1.81% | -2.99% | — | |
| 15 | RARE | Ultragenyx Pharmaceutical In | 股票-其他 | 1.79% | -0.78% | +29.60% | |
| 16 | ✓ | Ikena Oncology Inc | 股票-其他 | 1.69% | — | — | |
| 17 | 260 | Centessa Pharmaceuticals-adr | 股票-其他 | 1.46% | — | +43.18% | |
| 18 | CNTX | Context Therapeutics Inc | 股票-其他 | 1.45% | -3.34% | +15.89% | |
| 19 | SGMT | Sagimet Biosciences Inc-a | 股票-其他 | 1.40% | +1.00% | +0.34% | |
| 20 | EYPT | Eyepoint Inc | 股票-其他 | 1.39% | -1.52% | +19.47% | |
| 21 | PLRX | Pliant Therapeutics Inc | 股票-其他 | 1.29% | -1.01% | EXIT | |
| 22 | PVLA | Palvella Therapeutics Inc | 股票-其他 | 1.27% | -0.22% | -43.91% | |
| 23 | RPTX | Repare Therapeutics Inc | 股票-其他 | 1.09% | — | — | |
| 24 | ETWOGBP | E2open Parent Holdings Inc | 股票-其他 | 1.06% | — | — | |
| 25 | MLYS | Mineralys Therapeutics Inc | 股票-其他 | 1.06% | — | — | |
| 26 | CMPS | Compass Pathways PLC | 股票-其他 | 1.05% | +0.96% | NEW | |
| 27 | TNGX | Tango Therapeutics Inc | 股票-其他 | 0.94% | — | +22.49% | |
| 28 | KROS | Keros Therapeutics Inc | 股票-其他 | 0.87% | — | +9.64% | |
| 29 | AQST | Aquestive Therapeutics Inc | 股票-其他 | 0.86% | -0.91% | +2.22% | |
| 30 | NN | Nextnav Inc | 股票-其他 | 0.78% | — | — | |
| 31 | ✓ | Marblegate Acquisition Corp | 股票-其他 | 0.44% | — | — | |
| 32 | VRNA | Verona Pharma PLC - Adr | 股票-其他 | 0.38% | — | — | |
| 33 | EPD | Enterprise Products Partners | 股票-能源 | 0.34% | -0.32% | EXIT | |
| 34 | ✓ | Adc Therapeutics SA | 股票-其他 | 0.33% | -0.58% | — | |
| 35 | ✓ | Inozyme Pharma Inc | 股票-其他 | 0.32% | — | — | |
| 36 | GOCOQ | Gohealth Inc-class A | 股票-其他 | 0.22% | -0.02% | EXIT | |
| 37 | MRKR | Marker Therapeutics Inc | 股票-其他 | 0.22% | -0.07% | — | |
| 38 | ✓ | Alpha Modus Hldgs Inc | 股票-其他 | 0.15% | -0.04% | EXIT | |
| 39 | ROIV | Roivant Sciences Ltd. | 股票-医疗保健 | 0.13% | — | — | |
| 40 | SHFS | Shf Holdings Inc | 股票-其他 | 0.11% | -0.02% | — | |
| 41 | CAH | Cardinal Health Inc | 股票-医疗保健 | 0.08% | -0.10% | EXIT | |
| 42 | ✓ | 股票-其他 | 0.07% | — | — | ||
| 43 | SLND-WS | Legato Merger CORP Ii -cw23 | 股票-其他 | 0.04% | -0.01% | — | |
| 44 | NIOBW | Niocorp Developments LTD -28 | 股票-其他 | 0.04% | -0.08% | — | |
| 45 | ✓ | Rezolve Ai LTD | 股票-其他 | 0.04% | -0.02% | — | |
| 46 | AMODW | Insight Acquisition Co -cw23 | 股票-其他 | 0.03% | -0.01% | +56.12% | |
| 47 | ✓ | Marblegate Acquisition CORP | 股票-其他 | 0.03% | — | — | |
| 48 | ✓ | Critical Metals CORP | 股票-其他 | 0.03% | — | — | |
| 49 | BKSY-WS | Blacksky Technology -cw24 | 股票-其他 | 0.01% | — | — | |
| 50 | OPTXW | Omnilit Acquisition Cl A -23 | 股票-其他 | 0.01% | -0.23% | EXIT |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | NCDL | Nuveen Churchill Direct Lend | +6.5% | — | 不变 |
| 2 | TQQQ | Proshares Ultrapro Qqq | +3.2% | NEW | 新建仓 |
| 3 | CVEO | Civeo CORP | +2.6% | NEW | 新建仓 |
| 4 | OBDC | Blue Owl Capital CORP | +2.6% | — | 不变 |
| 5 | HLLY | Holley Inc | +2.3% | +77.84% | 加仓 |
| 6 | EVCM | Evercommerce Inc | +1.2% | — | 不变 |
| 7 | MLYS | Mineralys Therapeutics Inc | +1.1% | NEW | 新建仓 |
| 8 | CMPS | Compass Pathways PLC | +0.9% | +604.44% | 加仓 |
| 9 | CMPX | Compass Therapeutics Inc | +0.8% | — | 不变 |
| 10 | NN | Nextnav Inc | +0.8% | NEW | 新建仓 |
| 11 | RARE | Ultragenyx Pharmaceutical In | +0.6% | +29.60% | 加仓 |
| 12 | 260 | Centessa Pharmaceuticals-adr | +0.6% | +43.18% | 加仓 |
| 13 | PVLA | Palvella Therapeutics Inc | +0.6% | -43.91% | 减仓 |
| 14 | IRON | Disc Medicine Inc | +0.5% | +16.63% | 加仓 |
| 15 | VRNA | Verona Pharma PLC - Adr | +0.4% | NEW | 新建仓 |
| 16 | ✓ | Marblegate Acquisition Corp | +0.3% | — | 不变 |
| 17 | EYPT | Eyepoint Inc | +0.2% | +19.47% | 加仓 |
| 18 | ✓ | Alpha Modus Hldgs Inc | +0.2% | NEW | 新建仓 |
| 19 | ✓ | Ikena Oncology Inc | +0.1% | — | 不变 |
| 20 | ELDN | Eledon Pharmaceuticals Inc | +0.1% | -7.14% | 减仓 |
| 21 | AQST | Aquestive Therapeutics Inc | +0.1% | +2.22% | 加仓 |
| 22 | SHFS | Shf Holdings Inc | +0.1% | NEW | 新建仓 |
| 23 | TRML | Tourmaline Bio Inc | +0.1% | -3.91% | 减仓 |
| 24 | RPTX | Repare Therapeutics Inc | +0.1% | — | 不变 |
| 25 | ETWOGBP | E2open Parent Holdings Inc | +0.1% | — | 不变 |
| 26 | SGMT | Sagimet Biosciences Inc-a | 0% | +0.34% | 加仓 |
| 27 | KROS | Keros Therapeutics Inc | 0% | +9.64% | 加仓 |
| 28 | ✓ | Adc Therapeutics SA | 0% | — | 不变 |
| 29 | PLMKW | Plum Acquisition Corp. IV | 0% | EXIT | 清仓 |
| 30 | OPTX | Syntec Optics Holdings Inc | 0% | EXIT | 清仓 |
| 31 | ✓ | Alpha Partners Technology Merg | -0.1% | EXIT | 清仓 |
| 32 | ✓ | Rezolve Ai LTD | -0.1% | — | 不变 |
| 33 | ✓ | -0.1% | — | 不变 | |
| 34 | CNTX | Context Therapeutics Inc | -0.1% | +15.89% | 加仓 |
| 35 | ✓ | Engene Holdings Inc | -0.1% | +3.78% | 加仓 |
| 36 | GTLB | Gitlab Inc-cl A | -0.1% | EXIT | 清仓 |
| 37 | ✓ | -0.2% | EXIT | 清仓 | |
| 38 | MRKR | Marker Therapeutics Inc | -0.2% | — | 不变 |
| 39 | OHI | Omega Healthcare Investors, Inc. | -0.2% | EXIT | 清仓 |
| 40 | CNDT | Conduent Inc | -0.3% | +1.28% | 加仓 |
| 41 | TNGX | Tango Therapeutics Inc | -0.3% | +22.49% | 加仓 |
| 42 | ✓ | Inozyme Pharma Inc | -0.4% | — | 不变 |
| 43 | ✓ | -0.4% | EXIT | 清仓 | |
| 44 | MREO | Mereo Biopharma Group Pl-adr | -0.5% | EXIT | 清仓 |
| 45 | CGEM | Cullinan Therapeutics Inc | -0.7% | +2.74% | 加仓 |
| 46 | LRMR | Larimar Therapeutics Inc | -0.8% | +2.69% | 加仓 |
| 47 | ✓ | Acelyrin Inc | -2% | EXIT | 清仓 |
| 48 | GOCOQ | Gohealth Inc-class A | -2.4% | -69.86% | 减仓 |
| 49 | PLRX | Pliant Therapeutics Inc | -7.1% | +7.22% | 加仓 |
| 50 | KVYO | Klaviyo Inc-a | -10.3% | EXIT | 清仓 |
根据 SEC 官方 Form 13F 申报备案，Blue Owl Capital Holdings LP 在 Q1 2025 季度的美股持仓总市值约为 US$6.6亿，共申报了 73 个公开持股仓位。
在 Q1 2025 季度，Blue Owl Capital Holdings LP 按市值排列的前三大核心持股分别为：NCDL (22.1%)、OBDC (9.7%)、CGEM (6.0%)。其中最大持股仓位 NCDL 占据整体投资组合约 22.1% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
TQQQ
市值: US$1002.8万
本季最大获利了结 / 清仓标的
KVYO
前期市值: US$4448.8万
在 Q1 2025 季度中，Blue Owl Capital Holdings LP 共进行了 37 项持仓异动，包含新建仓 7 个仓位、加仓 16 个仓位、减仓 4 个仓位以及清仓 10 个仓位。 其中最大新建仓标的为 TQQQ。 本季清仓仓位包含 KVYO。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。